Document Detail


Metacarpophalangeal joints in rheumatoid arthritis: delayed gadolinium-enhanced MR imaging of cartilage--a feasibility study.
MedLine Citation:
PMID:  20807848     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To evaluate the feasibility of delayed gadolinium-enhanced magnetic resonance (MR) imaging of the cartilage of metacarpophalangeal (MCP) joints in patients with rheumatoid arthritis (RA) compared with that in control subjects.
MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained. Thirty-one MCP joints in 10 patients with RA (mean age, 59 years; range, 35-77 years) and six healthy volunteers (mean age, 51 years; range, 30-71 years) were examined with delayed gadolinium-enhanced MR imaging of cartilage. Sagittal images of the second and third MCP joints (hereafter, MCP II and MCP III) were acquired with a three-dimensional dual-flip-angle gradient-echo sequence at 3.0 T. B(1) field inhomogeneity-corrected T1 maps were calculated, and delayed gadolinium-enhanced MR imaging of cartilage values for phalangeal and metacarpal cartilage were determined. In addition, cartilage thickness was measured. A nonparametric Mann-Whitney U test was used to assess differences between groups.
RESULTS: Phalangeal and metacarpal delayed gadolinium-enhanced MR imaging of cartilage values in patients with RA (MCP II: 388 msec ± 105 [standard deviation] and 342 msec ± 79, respectively; MCP III: 409 msec ± 96 and 371 msec ± 89, respectively) were significantly lower than in control subjects (MCP II: 598 msec ± 62 and 560 msec ± 51, respectively; MCP III: 586 msec ± 57 and 561 msec ± 80, respectively). Cartilage thickness of both joints was comparable in patients with RA (MCP II: 1.28 mm ± 0.50, MCP III: 1.17 mm ± 0.24) and control subjects (MCP II: 1.42 mm ± 0.33, MCP III: 1.18 mm ± 0.26).
CONCLUSION: Delayed gadolinium-enhanced MR imaging of cartilage of the MCP joints is feasible at 3.0 T. Delayed gadolinium-enhanced MR imaging of cartilage may help to assess cartilage degeneration in morphologically normal-appearing MCP II and III cartilage in patients with RA.
Authors:
Falk R Miese; Benedikt Ostendorf; Hans-Jörg Wittsack; Dorothea C Reichelt; Tallal C Mamisch; Christoph Zilkens; Rotem S Lanzman; Matthias Schneider; Axel Scherer
Related Documents :
15091128 - Bare area of the glenoid: magnetic resonance appearance with arthroscopic correlation.
3611428 - Destructive cartilage loss in the joints of adult male broiler breeding fowls.
9243968 - Magnetic resonance imaging in primary and secondary septorhinoplasty.
22335228 - Tumour hyperthermia and ablation in rats using a clinical mr-hifu system equipped with ...
3518368 - Hemorrhagic focal bacterial nephritis: findings on gray-scale sonography and ct.
21943948 - Peritoneal computed tomography attenuation values reflect the severity of peritonitis c...
Publication Detail:
Type:  Journal Article     Date:  2010-08-31
Journal Detail:
Title:  Radiology     Volume:  257     ISSN:  1527-1315     ISO Abbreviation:  Radiology     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-20     Completed Date:  2010-12-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401260     Medline TA:  Radiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  441-7     Citation Subset:  AIM; IM    
Copyright Information:
© RSNA, 2010.
Affiliation:
Institute of Radiology, Heinrich-Heine-University, Moorenstrasse 5, 40225 Düsseldorf, Germany. falk.miese @med.uni-duesseldorf.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Arthritis, Rheumatoid / pathology*
Cartilage, Articular / pathology*
Case-Control Studies
Contrast Media / diagnostic use*
Feasibility Studies
Female
Gadolinium DTPA / diagnostic use*
Humans
Image Interpretation, Computer-Assisted
Imaging, Three-Dimensional
Magnetic Resonance Imaging / methods*
Male
Metacarpophalangeal Joint / pathology*
Middle Aged
Statistics, Nonparametric
Chemical
Reg. No./Substance:
0/Contrast Media; 80529-93-7/Gadolinium DTPA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Urinary calculi composed of uric acid, cystine, and mineral salts: differentiation with dual-energy ...
Next Document:  Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer?